These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4901556)

  • 21. [Activity of prodigiozan by various routes of administration and during non-specific stimulation of local (regional) defense mechanisms].
    Givental' NI
    Antibiotiki; 1971; 16(4):345-50. PubMed ID: 4936028
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience in the use of prodigiozan in the treatment of chronic bronchitis in miners].
    Grinzaĭd MI; Al'berton NI; Balan GM; Lobova ZA; Rustemova DM
    Antibiotiki; 1969 Jun; 14(6):546-9. PubMed ID: 4389961
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience in the use of prodigiozan in the treatment of chronic inflammatory diseases of the female reproductive organs].
    Matveeva EE; Zhukovskaia LN
    Akush Ginekol (Mosk); 1967 Dec; 43(12):30-3. PubMed ID: 4889592
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of prodigiozan on the course of burns in dogs].
    Murashova NS; Koriakina IK; Nedoshivina RV; Golosova TV
    Antibiotiki; 1970 Dec; 15(12):1078-81. PubMed ID: 4322739
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of prodigiozan on the therapeutic effect and toxicity of some antitumor preparations].
    Veksler IG
    Antibiotiki; 1968 Jan; 13(1):72-7. PubMed ID: 4969473
    [No Abstract]   [Full Text] [Related]  

  • 26. [Increase of body resistance to infection and a stimulation of regenerative process under the combined effect of prodigiozan and methyluracil].
    Braude AI; Vaĭsberg GE; Skurkovich GV; Tatanenko LA; Shenĭuk LA
    Antibiotiki; 1971; 16(4):339-44. PubMed ID: 4936027
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunobiological aspects of using polysaccharides of bacterial origin for treatment of young children with acute viral respiratory diseases].
    Andrushchuk AO; Rudkovskaia NIe; Lisiana TA
    Pediatr Akus Ginekol; 1972 Oct; 5():5-6. PubMed ID: 4572663
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of prodigiozan for treating chronic pyelonephritis].
    Shul'tsev GP; Burtsev VI; Kharybin AK
    Ter Arkh; 1972 Jun; 44(6):90-3. PubMed ID: 4587447
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prodigiozan stimulation of the defense reactions of the organism sustaining a severe toxicoinfectious process].
    Givental' NI
    Antibiotiki; 1970 Apr; 15(4):335-40. PubMed ID: 4923029
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chinese herbal drugs: sheng-bai-kuai in the treatment of leukopenia caused by chemotherapy].
    Tan D; Xie ZZ; Zhong M; Wu D; Liang X; Li W; Qin Q; Tam G
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):547-9. PubMed ID: 10073005
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and immunological effectiveness of prodigiozan in suppurative surgical diseases].
    Grinzaĭd MI; Snopkova VA; Bilich GL; Shedlovskaia MV
    Antibiotiki; 1969 Nov; 14(11):1049-53. PubMed ID: 4907801
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of irradiated guinea pigs with the polysaccharide prodigiozan].
    Chertkov KS; Mosina ZM; Khramchenkova SP
    Radiobiologiia; 1976; 16(1):88-91. PubMed ID: 775528
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of prodigiozan in the overall therapy of dysentery in children].
    Sosnova MA; Zelenaia SN
    Zdravookhr Kirg; 1976; (6):19-21. PubMed ID: 13573
    [No Abstract]   [Full Text] [Related]  

  • 34. [Protective effect of Prodigiozan in experimental infections].
    Bukharin OV; Iakovleva ZM
    Biull Eksp Biol Med; 1966 Aug; 62(8):68-70. PubMed ID: 4914818
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental-clinical study of combined use of antibiotics and prodigiozan].
    Vaĭsberg GE; Taranenko LA; Zhukovskaia LN
    Antibiotiki; 1967 Nov; 12(11):1040-3. PubMed ID: 4298568
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of olivomycin and bruneomycin and their combined use with prodigiozan on some nonspecific defense reactions of the host organism of transplanted lymphadenosis NK-LI].
    Shapovalova SP
    Antibiotiki; 1970 Oct; 15(10):924-8. PubMed ID: 4924376
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of prodigiozan in treating vibration disease].
    Balan GM; Cherkasskaia RG
    Gig Tr Prof Zabol; 1977 Apr; (4):32-6. PubMed ID: 323109
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of prodigiozan in serosols after cryotonsillotomy].
    Timofeev VT; Mukhitdinov ShM
    Vestn Otorinolaringol; 1975; (1):59-61. PubMed ID: 1090061
    [No Abstract]   [Full Text] [Related]  

  • 39. [Microflora of the upper respiratory tract and state of immunity in patients with chronic tonsillitis treated with prodigiozan combined with antibiotics].
    Golosova GV; Anikina TP; Skurkovich GV
    Antibiotiki; 1970 Oct; 15(10):946-50. PubMed ID: 4922626
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prodigiozane in the therapy of skin and venereal diseases].
    Rozentul MA; Studnitsin AA; Maslov PE; Egorov GI; Toporovskiĭ LM; Ovsiannikov LM; Androsova AA; Kovalenko GI
    Vestn Dermatol Venerol; 1966 Oct; 40(10):46-7. PubMed ID: 4872451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.